- Trials with a EudraCT protocol (8)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
8 result(s) found for: Snoring.
Displaying page 1 of 1.
EudraCT Number: 2011-001779-38 | Sponsor Protocol Number: MRZ60201_2069_1 | Start Date*: 2011-11-30 | |||||||||||
Sponsor Name:Merz Pharmaceuticals GmbH | |||||||||||||
Full Title: Prospective, randomized, double-blind, placebo-controlled, parallel-group, 3-stage dose-finding study to identify a safe and effective dose of NT 201 for unilateral injection into the soft palate f... | |||||||||||||
Medical condition: Habitual snoring | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-001497-27 | Sponsor Protocol Number: BY1023/M3-713 | Start Date*: 2005-08-12 |
Sponsor Name:ALTANA Pharma AG | ||
Full Title: Effect of pantoprazole on sleep-related breathing disorders | ||
Medical condition: Sleep-related breathing disorders | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-004620-10 | Sponsor Protocol Number: 719-13 | Start Date*: 2014-12-22 |
Sponsor Name:Johan Hellgren | ||
Full Title: A double blind, placebo controlled randomized study of nasal steroid spray treatment on the quality of life and objective sleep parameters in children with sleep disorder breathing. | ||
Medical condition: Sleep disordered breathing due to enlarged tonsils and/or adenoid | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-004917-10 | Sponsor Protocol Number: P05155 | Start Date*: 2015-03-03 |
Sponsor Name:Schering-Plough S.A. de C.V. | ||
Full Title: A Double-Blind Placebo-Controlled, Randomized, Parallel-Group, Multicenter Clinical Trial To Evaluate Efficacy And Safety Of Mometasone Furoate Nasal Spray In Children With Adenoid Hypertrophy. SNO... | ||
Medical condition: Adenoid Hypertrophy. | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2017-004539-36 | Sponsor Protocol Number: 16NC06 | Start Date*: 2020-05-19 | ||||||||||||||||
Sponsor Name:Great Ormond Street Hospital for Children NHS Foundation Trust | ||||||||||||||||||
Full Title: Study of Montelukast In Children with Sickle Cell Disease (SMILES) | ||||||||||||||||||
Medical condition: Sleep-disordered breathing | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2023-000062-34 | Sponsor Protocol Number: Reb-Oxy-OSA | Start Date*: 2023-06-02 | |||||||||||
Sponsor Name:CHU Brugmann | |||||||||||||
Full Title: Combination of Reboxetine 4mg and Oxybutynin 5mg for treating moderate obstructive sleep apnea: a one-month randomized placebo-controlled double-blind study | |||||||||||||
Medical condition: Obstructive sleep apnea | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-000733-37 | Sponsor Protocol Number: 21402 | Start Date*: 2005-08-20 | |||||||||||
Sponsor Name:NV Organon | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled, multicenter parallel-group dose ranging clinical trial to assess the efficacy and safety of Org 4419-2 in the treatment of obstructive sleep apnea/hy... | |||||||||||||
Medical condition: Obstructive sleep apnea/hypopnea syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-000469-39 | Sponsor Protocol Number: B9R-HL-GDGN | Start Date*: 2007-05-02 | |||||||||||
Sponsor Name:Oy Eli Lilly Finland Ab | |||||||||||||
Full Title: An Open Label Follow-up Study of Patients Who Participated in Clinical Study B9R-HL-GDDV. A Phase IV, one-arm follow-up study to assess final adult results of GH treatment in patients with the Pra... | |||||||||||||
Medical condition: Prader-Willi syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
